Endoscopy: Transoral (Upper) Endoscopy – Complications
Complications
Esophageal Perforation
- Upper Endoscopy is the Most Common Cause of Esophageal Perforation
- Risk:
- Pneumatic Dilation for Achalasia: 2-6% (Highest Risk)
- Stricture Dilation: 0.09-2.2%
- Sclerotherapy: < 1%
- Diagnostic Endoscopy with a Rigid Endoscope: 0.11%
- Diagnostic Endoscopy with a Flexible Endoscope: 0.03%
- Diagnosis/Treatment:
Bleeding
- Risks:
- Sphincterotomy
- Endoscopic Mucosal Resection
- Esophageal Dilation
- Percutaneous Endoscopic Gastrostomy (PEG) Placement
- Severity:
- Mild: Clinical Evidence (Not Just Endoscopic) with Hgb Drop < 3 g/dL without Transfusion
- Moderate: Transfusion ≤ 4 Units without Any Angiographic or Surgical Intervention
- Severe: Transfusion ≥ 5 Units or Requiring Angiographic or Surgical Intervention
- ERCP Bleeding Prevention:
- Use Blended Mode for Sphincterotomy (Compared to Pure-Cut)
- Prophylactic Injection of Hypertonic Saline-Epinephrine Proximal to the Papilla
- Consider Endoscopic Papillary Large-Balloon Dilation (EPLBD) without Sphincterotomy for Coagulopathic Patients at Increased Risk
- Treatment:
- Initial: Endoscopic Therapy
- Dilute Epinephrine Injection
- Electrocautery
- Endoscopic Clips
- Balloon Tamponade
- If Refractory: Angiographic Embolization or Surgery
- Equally Effective – Angiography Generally Preferred if Available
- Initial: Endoscopic Therapy
Infection
- Cholangitis
- Cholecystitis
- Rarely Hepatitis B & Hepatitis C Have Been Seen Due to Breaches in Disinfection Protocol
Post-ERCP Pancreatitis (PEP)
- Risk: 9.7% – Most Common Complication After ERCP
- Risk Factors:
- Patient-Related:
- History of Post-ERCP Pancreatitis
- Female Sex
- History of Recurrent Pancreatitis
- Suspected Sphincter of Oddi Dysfunction
- Younger Age (< 40 Years)
- Absence of Chronic Pancreatitis
- Normal Serum Bilirubin
- Procedure-Related:
- Difficult Cannulation (> 10 Attempts)
- Repetitive Pancreatic Guidewire Cannulation
- Pancreatic Injection
- Pancreatic Sphincterotomy
- Endoscopic Papillary Large-0Balloon Dilation of an Intact Sphincter
- Diagnostic Procedure (vs Therapeutic)
- Patient-Related:
- Prevention:
- Pancreatic Duct Stenting
- Decreases Risk but Requires Later Removal After 1-2 Weeks
- Generally Used Only in High-Risk/Difficult Cases (Not Routinely)
- Rectal NSAID’s (Indomethacin)
- Decreases Risk of PEP
- Oral NSAID’s Have Not Demonstrated the Same Effect
- Pancreatic Duct Stenting
- Treatment: Supportive Management